Poster Session E - Tuesday Afternoon
Category: GI Bleeding
Apoorva Chandar, MBBS, MPH
Case Western Reserve University
Cleveland, Ohio
| Unmatched cohorts | Propensity matched cohorts | ||
| Colonoscopy < 7 days (N = 13,890) | Colonoscopy > 7 days (N = 103,718) | Colonoscopy < 7 days (N = 12,502) | Colonoscopy > 7 days (N = 12,502) |
Age at index | 63.4 +/- 15.2 years | 64.2 +/- 15.9 years | 63.4 +/- 15.2 years | 63.4 +/- 15.3 years |
White race | 8,752 (70%) | 67,415 (68.7%) | 8,752 (70%) | 8,889 (71.1%) |
Male | 5,717 (45.7%) | 43,326 (44.1%) | 5,717 (45.7%) | 5,648 (45.2%) |
Nicotine dependence | 1,536 (12.3%) | 11,435 (11.7%) | 1,536 (12.3%) | 1,414 (11.3%) |
Alcohol abuse | 496 (4%) | 3,196 (3.3%) | 496 (4%) | 391 (3.1%) |
Hypertension | 6,547 (52.4%) | 50,258 (51.2%) | 6,547 (52.4%) | 6,611 (52.9%) |
Chronic kidney disease | 1,351 (10.8%) | 11,523 (11.7%) | 1,351 (10.8%) | 1,272 (10.2%) |
Type 2 diabetes | 2,579 (20.6%) | 20,162 (20.5%) | 2,579 (20.6%) | 2,532 (20.5%) |
BMI ≥ 30 | 4,424 (35.4%) | 29,734 (30.3% | 4,424 (35.4%) | 4,090 (32.7%) |
Atherosclerosis | 633 (5.1%) | 5,812 (5.9%) | 633 (5.1%) | 544 (4.4%) |
NSAID use | 3,921 (31.4%) | 29,896 (30.5%) | 3,921 (31.4%) | 4,017 (32.1%) |
Anticoagulant use | 2,810 (22.5%) | 21,327 (21.7%) | 2,810 (22.5%) | 2,792 (22.3%) |
Anti-platelet agent use | 3,532 (28.3%) | 24,942 (25.4%) | 3,532 (28.3%) | 3,459 (27.7%) |